Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rogier W Sanders

Showing results (261-270 of 327) with videos related to

Pageof 33
Sort By:
Cell|February 1, 2020
Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing AntibodyPhilipp Schommers, Henning Gruell, Morgan E Abernathy, et al.
Biochemistry|July 2, 2021
Site-Specific Steric Control of SARS-CoV-2 Spike GlycosylationJoel D Allen, Himanshi Chawla, Firdaus Samsudin, et al.
Science Translational Medicine|January 20, 2017
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controllerNatalia T Freund, Haoqing Wang, Louise Scharf, et al.
Biorxiv : the Preprint Server for Biology|October 20, 2022
Broad SARS-CoV-2 Neutralization by Monoclonal and Bispecific Antibodies Derived from a Gamma-infected IndividualDenise Guerra, Tim Beaumont, Laura RadiÄ, et al.
AIDS (London, England)|September 13, 2023
Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infectionPien M van Paassen, Lisa van Pul, Karlijn van der Straten, et al.
Communications Biology|June 5, 2026
Early immune events during SARS-CoV-2 infection impact memory T and B cell responsesKyra Woloszczuk, David Joyner, Jennifer Connors, et al.
Cell Reports|April 7, 2021
Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spikeRonald Derking, Joel D Allen, Christopher A Cottrell, et al.
Nature Structural & Molecular Biology|May 28, 2013
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120Leopold Kong, Jeong Hyun Lee, Katie J Doores, et al.
Cell Host & Microbe|November 18, 2022
Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protectionPhilip J M Brouwer, Aleksandar Antanasijevic, Adam J Ronk, et al.
Iscience|October 16, 2023
Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individualDenise Guerra, Tim Beaumont, Laura Radić, et al.
Pageof 33

Showing results (261-270 of 327) with videos related to

Sort By:
Pageof 33
Cell|February 1, 2020
Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing AntibodyPhilipp Schommers, Henning Gruell, Morgan E Abernathy, et al.
Biochemistry|July 2, 2021
Site-Specific Steric Control of SARS-CoV-2 Spike GlycosylationJoel D Allen, Himanshi Chawla, Firdaus Samsudin, et al.
Science Translational Medicine|January 20, 2017
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controllerNatalia T Freund, Haoqing Wang, Louise Scharf, et al.
Biorxiv : the Preprint Server for Biology|October 20, 2022
Broad SARS-CoV-2 Neutralization by Monoclonal and Bispecific Antibodies Derived from a Gamma-infected IndividualDenise Guerra, Tim Beaumont, Laura RadiÄ, et al.
AIDS (London, England)|September 13, 2023
Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infectionPien M van Paassen, Lisa van Pul, Karlijn van der Straten, et al.
Communications Biology|June 5, 2026
Early immune events during SARS-CoV-2 infection impact memory T and B cell responsesKyra Woloszczuk, David Joyner, Jennifer Connors, et al.
Cell Reports|April 7, 2021
Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spikeRonald Derking, Joel D Allen, Christopher A Cottrell, et al.
Nature Structural & Molecular Biology|May 28, 2013
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120Leopold Kong, Jeong Hyun Lee, Katie J Doores, et al.
Cell Host & Microbe|November 18, 2022
Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protectionPhilip J M Brouwer, Aleksandar Antanasijevic, Adam J Ronk, et al.
Iscience|October 16, 2023
Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individualDenise Guerra, Tim Beaumont, Laura Radić, et al.
Pageof 33